BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

976 related articles for article (PubMed ID: 29437850)

  • 1. Targeting the HUβ Protein Prevents Porphyromonas gingivalis from Entering into Preexisting Biofilms.
    Rocco CJ; Bakaletz LO; Goodman SD
    J Bacteriol; 2018 Jun; 200(11):. PubMed ID: 29437850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural antigenic differences in the functionally equivalent extracellular DNABII proteins of bacterial biofilms provide a means for targeted biofilm therapeutics.
    Rocco CJ; Davey ME; Bakaletz LO; Goodman SD
    Mol Oral Microbiol; 2017 Apr; 32(2):118-130. PubMed ID: 26988714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the Streptococcus gordonii SspB protein in the development of Porphyromonas gingivalis biofilms on streptococcal substrates.
    Lamont RJ; El-Sabaeny A; Park Y; Cook GS; Costerton JW; Demuth DR
    Microbiology (Reading); 2002 Jun; 148(Pt 6):1627-1636. PubMed ID: 12055284
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Tan J; Patil PC; Luzzio FA; Demuth DR
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29760142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BAR-encapsulated nanoparticles for the inhibition and disruption of Porphyromonas gingivalis-Streptococcus gordonii biofilms.
    Mahmoud MY; Demuth DR; Steinbach-Rankins JM
    J Nanobiotechnology; 2018 Sep; 16(1):69. PubMed ID: 30219060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural competence is a major mechanism for horizontal DNA transfer in the oral pathogen Porphyromonas gingivalis.
    Tribble GD; Rigney TW; Dao DH; Wong CT; Kerr JE; Taylor BE; Pacha S; Kaplan HB
    mBio; 2012; 3(1):. PubMed ID: 22294679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Label-free quantitative proteomic analysis of the oral bacteria Fusobacterium nucleatum and Porphyromonas gingivalis to identify protein features relevant in biofilm formation.
    Ali Mohammed MM; Pettersen VK; Nerland AH; Wiker HG; Bakken V
    Anaerobe; 2021 Dec; 72():102449. PubMed ID: 34543761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of Porphyromonas gingivalis with oral streptococci requires a motif that resembles the eukaryotic nuclear receptor box protein-protein interaction domain.
    Daep CA; Lamont RJ; Demuth DR
    Infect Immun; 2008 Jul; 76(7):3273-80. PubMed ID: 18474648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional assessment of peptide-modified PLGA nanoparticles against oral biofilms in a murine model of periodontitis.
    Mahmoud MY; Steinbach-Rankins JM; Demuth DR
    J Control Release; 2019 Mar; 297():3-13. PubMed ID: 30690103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization and development of SAPP as a specific peptidic inhibitor that targets Porphyromonas gingivalis.
    Ho MH; Lamont RJ; Chazin WJ; Chen H; Young DF; Kumar P; Xie H
    Mol Oral Microbiol; 2018 Dec; 33(6):430-439. PubMed ID: 30298683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The activity of bacterial peptidylarginine deiminase is important during formation of dual-species biofilm by periodontal pathogen Porphyromonas gingivalis and opportunistic fungus Candida albicans.
    Karkowska-Kuleta J; Bartnicka D; Zawrotniak M; Zielinska G; Kieronska A; Bochenska O; Ciaston I; Koziel J; Potempa J; Baster Z; Rajfur Z; Rapala-Kozik M
    Pathog Dis; 2018 Jun; 76(4):. PubMed ID: 29668945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aggregatibacter actinomycetemcomitans mediates protection of Porphyromonas gingivalis from Streptococcus sanguinis hydrogen peroxide production in multi-species biofilms.
    Zhu B; Macleod LC; Newsome E; Liu J; Xu P
    Sci Rep; 2019 Mar; 9(1):4944. PubMed ID: 30894650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide-modified nanoparticles inhibit formation of
    Kalia P; Jain A; Radha Krishnan R; Demuth DR; Steinbach-Rankins JM
    Int J Nanomedicine; 2017; 12():4553-4562. PubMed ID: 28790818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular pathways underlying inhibitory effect of antimicrobial peptide Nal-P-113 on bacteria biofilms formation of Porphyromonas gingivalis W83 by DNA microarray.
    Wang HY; Lin L; Tan LS; Yu HY; Cheng JW; Pan YP
    BMC Microbiol; 2017 Feb; 17(1):37. PubMed ID: 28212615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Resveratrol on biofilm formation and virulence factor gene expression of Porphyromonas gingivalis in periodontal disease.
    Kugaji MS; Kumbar VM; Peram MR; Patil S; Bhat KG; Diwan PV
    APMIS; 2019 Apr; 127(4):187-195. PubMed ID: 30861212
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Bartnicka D; Gonzalez-Gonzalez M; Sykut J; Koziel J; Ciaston I; Adamowicz K; Bras G; Zawrotniak M; Karkowska-Kuleta J; Satala D; Kozik A; Zyla E; Gawron K; Lazarz-Bartyzel K; Chomyszyn-Gajewska M; Rapala-Kozik M
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32183255
    [No Abstract]   [Full Text] [Related]  

  • 17. Streptococcus cristatus ArcA interferes with Porphyromonas gingivalis pathogenicity in mice.
    Xie H; Hong J; Sharma A; Wang BY
    J Periodontal Res; 2012 Oct; 47(5):578-83. PubMed ID: 22448761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic crosstalk regulates Porphyromonas gingivalis colonization and virulence during oral polymicrobial infection.
    Kuboniwa M; Houser JR; Hendrickson EL; Wang Q; Alghamdi SA; Sakanaka A; Miller DP; Hutcherson JA; Wang T; Beck DAC; Whiteley M; Amano A; Wang H; Marcotte EM; Hackett M; Lamont RJ
    Nat Microbiol; 2017 Nov; 2(11):1493-1499. PubMed ID: 28924191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomic and transcriptional analysis of interaction between oral microbiota Porphyromonas gingivalis and Streptococcus oralis.
    Maeda K; Nagata H; Ojima M; Amano A
    J Proteome Res; 2015 Jan; 14(1):82-94. PubMed ID: 25341202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tobacco smoke augments Porphyromonas gingivalis-Streptococcus gordonii biofilm formation.
    Bagaitkar J; Daep CA; Patel CK; Renaud DE; Demuth DR; Scott DA
    PLoS One; 2011; 6(11):e27386. PubMed ID: 22110637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.